HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells.

Abstract
Natural killer (NK) cells, early effectors in anticancer immunity, are paralyzed by TGFβ1, an immunosuppressive cytokine produced by cancer cells. Development and activity of NK cells are largely inhibited in the Smad3-dependent tumor microenvironment. Here, we used genetic engineering to generate a stable SMAD3-silencing human NK cell line, NK-92-S3KD, whose cancer-killing activity and cytokine production were significantly enhanced under TGFβ1-rich condition compared with the parental cell line. Interestingly, we identified that the IFNG gene is a direct E4BP4 target gene. Thus, silencing of SMAD3 allows upregulation of E4BP4 that subsequently promoting interferon-γ (IFNγ) production in the NK-92-S3KD cells. More importantly, NK-92-S3KD immunotherapy increases the production of not only IFNγ, but also granzyme B and perforin in tumors; therefore, inhibiting cancer progression in two xenograft mouse models with human hepatoma (HepG2) and melanoma (A375). Thus, the NK-92-S3KD cell line may be useful for the clinical immunotherapy of cancer. Cancer Immunol Res; 6(8); 965-77. ©2018 AACR.
AuthorsQing-Ming Wang, Patrick Ming-Kuen Tang, Guang-Yu Lian, Chunjie Li, Jinhong Li, Xiao-Ru Huang, Ka-Fai To, Hui-Yao Lan
JournalCancer immunology research (Cancer Immunol Res) Vol. 6 Issue 8 Pg. 965-977 (08 2018) ISSN: 2326-6074 [Electronic] United States
PMID29915022 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2018 American Association for Cancer Research.
Chemical References
  • Extracellular Matrix Proteins
  • SMAD3 protein, human
  • Smad3 Protein
  • Transforming Growth Factor beta
  • betaIG-H3 protein
  • Interferon-gamma
Topics
  • Animals
  • Cell Line
  • Extracellular Matrix Proteins (immunology)
  • Gene Silencing
  • Genetic Engineering (methods)
  • Humans
  • Immunotherapy (methods)
  • Interferon-gamma (biosynthesis)
  • Killer Cells, Natural (immunology)
  • Liver Neoplasms, Experimental (immunology, therapy)
  • Melanoma, Experimental (immunology, therapy)
  • Mice, Inbred NOD
  • Mice, Knockout
  • Smad3 Protein (genetics, immunology)
  • Transforming Growth Factor beta (immunology)
  • Tumor Microenvironment (immunology)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: